Literature DB >> 23281407

Adaptive immunity in atherogenesis: new insights and therapeutic approaches.

Andrew H Lichtman1, Christoph J Binder, Sotirios Tsimikas, Joseph L Witztum.   

Abstract

Many remarkable advances have improved our understanding of the cellular and molecular events in the pathogenesis of atherosclerosis. Chief among these is the accumulating knowledge of how the immune system contributes to all phases of atherogenesis, including well-known inflammatory reactions consequent to intimal trapping and oxidation of LDL. Advances in our understanding of the innate and adaptive responses to these events have helped to clarify the role of inflammation in atherogenesis and suggested new diagnostic modalities and novel therapeutic targets. Here we focus on recent advances in understanding how adaptive immunity affects atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23281407      PMCID: PMC3533280          DOI: 10.1172/JCI63108

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  157 in total

1.  IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.

Authors:  Christoph J Binder; Karsten Hartvigsen; Mi-Kyung Chang; Marina Miller; David Broide; Wulf Palinski; Linda K Curtiss; Maripat Corr; Joseph L Witztum
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 2.  A killer on the road: circulating CD4(+)CD28null T cells as cardiovascular risk factor in ESRD patients.

Authors:  Michiel G H Betjes; Ruud W J Meijers; Lucia E A de Wit; Nicolle H R Litjens
Journal:  J Nephrol       Date:  2012 Mar-Apr       Impact factor: 3.902

3.  Oxidized low-density lipoprotein and atherosclerosis.

Authors:  Daniel Steinberg; Joseph L Witztum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12       Impact factor: 8.311

Review 4.  Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events.

Authors:  Adam Taleb; Joseph L Witztum; Sotirios Tsimikas
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

5.  Interleukin 17: an unlikely marker of acute coronary syndrome?

Authors:  K D Patel; R T Murphy; M White; D Gasparro; D P Kelleher; T Ryan; R McManus; A W Ryan
Journal:  Atherosclerosis       Date:  2008-12-03       Impact factor: 5.162

Review 6.  Inhibition of interleukin-5 for the treatment of eosinophilic diseases.

Authors:  Jonathan Corren
Journal:  Discov Med       Date:  2012-04       Impact factor: 2.970

7.  T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse.

Authors:  H M Dansky; S A Charlton; M M Harper; J D Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

8.  Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions.

Authors:  R Kleindienst; Q Xu; J Willeit; F R Waldenberger; S Weimann; G Wick
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

Review 9.  Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.

Authors:  P Gounopoulos; E Merki; L F Hansen; S-H Choi; S Tsimikas
Journal:  Minerva Cardioangiol       Date:  2007-12       Impact factor: 1.347

10.  Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque.

Authors:  L Jonasson; J Holm; O Skalli; G Bondjers; G K Hansson
Journal:  Arteriosclerosis       Date:  1986 Mar-Apr
View more
  79 in total

1.  Atheroprotective vaccination with MHC-II-restricted ApoB peptides induces peritoneal IL-10-producing CD4 T cells.

Authors:  Takayuki Kimura; Kevin Tse; Sara McArdle; Teresa Gerhardt; Jacqueline Miller; Zbigniew Mikulski; John Sidney; Alessandro Sette; Dennis Wolf; Klaus Ley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-01-13       Impact factor: 4.733

Review 2.  Oxidation-specific epitopes as targets for biotheranostic applications in humans: biomarkers, molecular imaging and therapeutics.

Authors:  Yury I Miller; Sotirios Tsimikas
Journal:  Curr Opin Lipidol       Date:  2013-10       Impact factor: 4.776

Review 3.  Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention.

Authors:  M Wigren; J Nilsson; M J Kaplan
Journal:  J Intern Med       Date:  2015-11       Impact factor: 8.989

4.  HDL inhibits the effects of oxidized phospholipids on endothelial cell gene expression via multiple mechanisms.

Authors:  Benjamin Emert; Yehudit Hasin-Brumshtein; James R Springstead; Ladan Vakili; Judith A Berliner; Aldons J Lusis
Journal:  J Lipid Res       Date:  2014-05-23       Impact factor: 5.922

5.  Hypercholesterolemia Induced Immune Response and Inflammation on Progression of Atherosclerosis in Apob(tm2Sgy) Ldlr(tm1Her)/J Mice.

Authors:  Lakshmi Narasimha Rao; Thiruvelselvan Ponnusamy; Sheena Philip; Rupak Mukhopadhyay; Vijay V Kakkar; Lakshmi Mundkur
Journal:  Lipids       Date:  2015-07-16       Impact factor: 1.880

Review 6.  Mineralocorticoid receptors in immune cells: emerging role in cardiovascular disease.

Authors:  Nicholas C Bene; Pilar Alcaide; Henry H Wortis; Iris Z Jaffe
Journal:  Steroids       Date:  2014-04-21       Impact factor: 2.668

Review 7.  Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week.

Authors:  Peter Libby; Joseph Loscalzo; Paul M Ridker; Michael E Farkouh; Priscilla Y Hsue; Valentin Fuster; Ahmed A Hasan; Salomon Amar
Journal:  J Am Coll Cardiol       Date:  2018-10-23       Impact factor: 24.094

8.  Cardiovascular science: opportunities for translating research into improved care.

Authors:  Eugene Braunwald
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

9.  STAT4 deficiency reduces the development of atherosclerosis in mice.

Authors:  Parésa L Taghavie-Moghadam; Breanne N Gjurich; Rukhsana Jabeen; Purna Krishnamurthy; Mark H Kaplan; Anca D Dobrian; Jerry L Nadler; Elena V Galkina
Journal:  Atherosclerosis       Date:  2015-09-04       Impact factor: 5.162

Review 10.  Mineralocorticoid receptors in vascular disease: connecting molecular pathways to clinical implications.

Authors:  Adam P McGraw; Amy McCurley; Ioana R Preston; Iris Z Jaffe
Journal:  Curr Atheroscler Rep       Date:  2013-07       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.